Literature DB >> 29216684

The impact of Corynebacterium glucuronolyticum on semen parameters: a prospective pre-post-treatment study.

T Meštrović1,2, B Bedenić3,4, J Wilson5, S Ljubin-Sternak3,6, M Sviben3,7, M Neuberg2, R Ribić8, G Kozina2, Z Profozić1.   

Abstract

Corynebacterium glucuronolyticum (C. glucuronolyticum) is a rare isolate that is only recently being acknowledged as a potential urogenital pathogen. The bibliographical references on this bacterial species are scarce, and its influence on all semen parameters was hitherto unknown - therefore, the aim of this study was to evaluate its effects on a range of sperm quality parameters. A prospective approach to compare semen parameters before and after treatment was used in this study. C. glucuronolyticum in semen specimens was identified using analytical profile index biotyping system (API Coryne) and additionally confirmed by matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry (MALDI-TOF MS), with the determination of antimicrobial susceptibility by Kirby-Bauer method. Semen analysis was performed according to the criteria from the World Health Organization (with the use of Tygerberg method of sperm morphology categorization). Very strict inclusion criteria for participants also included detailed medical history and urological evaluation. From a total of 2169 screened semen specimens, the inclusion rate for participants with C. glucuronolyticum that satisfied all the criteria was 1.01%. Antibiogram-guided treatment of the infection with ensuing microbiological clearance has shown that the resolution of the infection correlates with statistically significant improvement in the vitality of spermatozoa, but also with a lower number of neck and mid-piece defects. Parameters such as sperm count, motility and normal morphology were not affected. In addition, susceptibility testing revealed a trend towards ciprofloxacin resistance, which is something that should be considered when selecting an optimal treatment approach. Albeit it is rarely encountered as a monoisolate in significant quantities, C. glucuronolyticum may negatively influence certain sperm parameters; therefore, it has to be taken into account in the microbiological analysis of urogenital samples.
© 2017 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  zzm321990Corynebacterium glucuronolyticumzzm321990; corynebacteria; genitourinary infection; infection; semen analysis; sperm quality parameters; spermatozoa

Mesh:

Year:  2017        PMID: 29216684     DOI: 10.1111/andr.12453

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  4 in total

1.  A microbial game of whack-a-mole: clinical case series of the urethral uncloaking phenomenon caused by Corynebacterium glucuronolyticum in men treated for Chlamydia trachomatis urethritis.

Authors:  Tomislav Meštrović
Journal:  Infection       Date:  2018-08-30       Impact factor: 3.553

Review 2.  Male genitourinary infections by Corynebacterium glucuronolyticum. A review and clinical experience.

Authors:  M Ruiz-Pino; C Foronda-García-Hidalgo; P Alarcón-Blanco; J Gutiérrez-Fernández
Journal:  Rev Esp Quimioter       Date:  2019-09-12       Impact factor: 1.553

3.  Comparative Semen Microbiota Composition of a Stallion in a Taylorella equigenitalis Carrier and Non-Carrier State.

Authors:  Carlota Quiñones-Pérez; Amparo Martínez; Francisco Crespo; José Luis Vega-Pla
Journal:  Animals (Basel)       Date:  2020-05-17       Impact factor: 2.752

4.  Age and sex-associated variation in the multi-site microbiome of an entire social group of free-ranging rhesus macaques.

Authors:  Amanda D Melin; James P Higham; Mareike C Janiak; Michael J Montague; Catalina I Villamil; Michala K Stock; Amber E Trujillo; Allegra N DePasquale; Joseph D Orkin; Samuel E Bauman Surratt; Olga Gonzalez; Michael L Platt; Melween I Martínez; Susan C Antón; Maria Gloria Dominguez-Bello
Journal:  Microbiome       Date:  2021-03-22       Impact factor: 14.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.